Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002733977 | SCV003736214 | uncertain significance | Inborn genetic diseases | 2021-10-22 | criteria provided, single submitter | clinical testing | The c.19A>G (p.T7A) alteration is located in exon 2 (coding exon 1) of the UMOD gene. This alteration results from a A to G substitution at nucleotide position 19, causing the threonine (T) at amino acid position 7 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005011191 | SCV005638570 | uncertain significance | Familial juvenile hyperuricemic nephropathy type 1 | 2024-01-08 | criteria provided, single submitter | clinical testing |